Perdiem

Dosage form: tablet
Ingredients: SENNOSIDES 15mg
Labeler: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
NDC code: 0067-8143

Medically reviewed by Drugs.com. Last updated on Jan 7, 2025.

Drug Facts

Active Ingredient

Sennosides 15 mg

Purpose

Stimulant Laxative

Uses

● relieves occasional constipation (irregularity)

● generally produces bowel movement in 6 to 12 hours

Warnings

Do not use laxative product when abdominal pain, nausea or vomiting are present unless directed by a doctor

Ask a doctor or pharmacist before use if you

● have noticed a sudden change in bowel habits that persists over a period of 2 weeks

● are taking any other drug. Take this product 2 or more hours before or after other drugs. Laxatives may affect how other drugs work.

When using this product

● do not use for a period longer than 1 week

Stop use and ask a doctor if

● rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

● swallow tablet with a glass of water

● swallow tablet whole, do not crush, break or chew

Adults and children 12 years of age and older	2 tablets once or twice daily
Children 6 to under 12 years of age	1 tablet once or twice daily
Children under 6 years of age	ask a doctor

Other Information

● each tablet contains: calcium 45mg, magnesium 5 mg

● store at controlled room temperature 20-25°C (68-77°F).

Inactive Ingredients

acacia, calcium carbonate, carnuba wax, corn starch, dibasic calcium phosphate, iron oxide black, iron oxide red, iron oxide yellow, magnesium stearate, methylparaben, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, propylene glycol, propylparaben, shellac, silicon dioxide, sodium benzoate, sodium lauryl sulfate, sucrose, talc, titanium dioxide

Questions?

call 1-855-297-3036

Package/Label Principal Display Panel

Primary Label

PERDIEM
sennosides, stimulant laxative tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0067-8143
Route of Administration	ORAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (SENNOSIDES)	SENNOSIDES	15 mg

Inactive Ingredients
Ingredient Name	Strength
ACACIA
CALCIUM CARBONATE
CARNAUBA WAX
STARCH, CORN
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
FERROSOFERRIC OXIDE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
MAGNESIUM STEARATE
METHYLPARABEN
MICROCRYSTALLINE CELLULOSE
POLYETHYLENE GLYCOL 3350
POLYVINYL ALCOHOL, UNSPECIFIED
POVIDONE, UNSPECIFIED
PROPYLENE GLYCOL
PROPYLPARABEN
SHELLAC
SILICON DIOXIDE
SODIUM BENZOATE
SODIUM LAURYL SULFATE
SUCROSE
TALC
TITANIUM DIOXIDE

Product Characteristics
Color	BROWN (Tan)	Score	no score
Shape	ROUND	Size	10mm
Flavor		Imprint Code	Perdiem
Contains

Packaging
#	Item Code	Package Description
1	NDC:0067-8143-01	1 BOTTLE in 1 CARTON
1		60 TABLET in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	07/01/2017

Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)

Revised: 01/2019

Document Id: dfaaddd8-c5f3-4943-aa75-3004c0466e06

Set id: 6b256c8f-3953-4c69-9a16-ffa0511bdbcd

Version: 3

Effective Time: 20190117

GlaxoSmithKline Consumer Healthcare Holdings (US) LLC

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Perdiem

Further information

See also:

Qulipta

Aimovig

Dupixent

Gemtesa

Ubrelvy

Nurtec ODT

Xeomin

Tazarotene topical

Topiramate

Dysport